Wells Fargo’s DexCom DXCM Stock Holding History

Wells Fargo’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-100	Closed	-$6.28K	–	7377
2026 Q1	$6.28K	Buy	+100	New	+$6.96K	﹤0.01%	6066
2025 Q3	–	Sell	-300	Closed	-$26.2K	–	7159
2025 Q2	$26.2K	Buy	+300	New	+$23.5K	﹤0.01%	5714
2019 Q4	–	Sell	-220,000	Closed	-$99K	–	6412
2019 Q3	$99K	Sell	220,000 -128,000	-37%	-$4.97M	﹤0.01%	5322
2019 Q2	$211K	Buy	+348,000	New	+$10.9M	﹤0.01%	4945

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Wells Fargo's DXCM Position: Q2 2026 in Review

Wells Fargo increased its DexCom (DXCM) stake by 20% in Q2 2026, buying an estimated $11.1M and bringing the position to 1,011,869 shares worth $68.1M. The position accounts for 0.01% of the portfolio, ranked #859.

Wells Fargo first reported a position in DXCM in Q2 2013 and has held it in 53 quarters since. The position peaked at $546M in Q3 2021. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Wells Fargo held 1,011,869 shares of DexCom worth $68.1M as of Q2 2026.
Wells Fargo bought 165,871 DexCom shares in Q2 2026, an estimated $11.1M.
DexCom made up 0.01% of Wells Fargo's portfolio in Q2 2026, its #859 holding.
Wells Fargo first reported a position in DexCom in Q2 2013 and has held it in 53 quarters since.
Wells Fargo's DexCom position peaked at $546M in Q3 2021.
974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.